🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT03399747
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
To explore the efficacy and safety of TQB2825 injection combined immunochem...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-04-23
Trial ID
NCT06829771
Treatments Being Tested
To assess the efficacy and safety of camrelizumab combined with rituximab, ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-01
Trial ID
NCT05093140
Treatments Being Tested
This study aims; to assess the efficacy of shortened systemic chemotherapy ...
Status
Unknown
Location
Asan Medical Center
Start Date
2010-08
Trial ID
NCT01279902
Treatments Being Tested
This study evaluates the addition of Acalabrutinib to current standard ther...
Status
Active Not Recruiting
Location
Colchester General Hospital
Start Date
2021-10-19
Trial ID
NCT04546620
Treatments Being Tested
The purpose of this study is to assess whether copanlisib in combination wi...
Status
Terminated
Location
Ironwood Physicians P.C. DBA Ironwood Cancer & Res. Ctr.
Start Date
2016-01-06
Trial ID
NCT02626455
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested
This is a Phase 3 study of the PI3Kδ inhibitor Zandelisib (ME-401) in combi...
Status
Terminated
Location
The Oncology Institute of Hope and Innovation
Start Date
2021-08-13
Trial ID
NCT04745832
Treatments Being Tested